Analyst consensus rating
Mirum Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
Mirum Pharmaceuticals's consensus rating is Strong Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $154.00.
Forecast evidence checked November 13, 2026.
Get free Mirum Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $93.33
- Average price target
- $154.00
- High price target
- $194.00
- Low price target
- $118.00
- Low target gap
- +26.4%
- Target upside
- +65%
- High target gap
- +107.9%
- Target range width
- 81.4%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Mirum Pharmaceuticals?
Mirum Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $154.00.
How far are Mirum Pharmaceuticals's low and high targets from the recorded price?
The low target implies +26.4%, while the high target implies +107.9%.
How many analysts are included in Mirum Pharmaceuticals's consensus?
The verified consensus includes 12 analysts.
How is Mirum Pharmaceuticals's target upside or downside calculated?
The average target of $154.00 is divided by the recorded price of $93.33, then one is subtracted to produce +65%. This does not guarantee a future return.
When was Mirum Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.